SBIR-STTR Award

Optimize Formulation of VSA Adjuvant
Award last edited on: 4/26/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$600,000
Award Phase
1
Solicitation Topic Code
105
Principal Investigator
Suzanne Michalek

Company Information

Adjuvax LLC

622 Renaissance Drive
Hoover, AL 35226
   (205) 936-0770
   contact@adjuvax.net
   www.adjuvax.net
Location: Single
Congr. District: 06
County: Jefferson

Phase I

Contract Number: 75N93022C00033
Start Date: 7/5/2022    Completed: 7/5/2024
Phase I year
2022
Phase I Amount
$600,000
The contract supports the development of a saponin as a vaccine adjuvant. The adjuvant development activities are being conducted within the context of vaccines to protect against SARS-CoV-2 and pneumococcal infection.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----